Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case--a modern Pandora's box

Biomed Pharmacother. 2002 Feb;56(1):56-9. doi: 10.1016/s0753-3322(01)00150-0.
No abstract available

MeSH terms

  • Cardiovascular Diseases / prevention & control
  • Cholesterol / metabolism*
  • Coenzymes
  • Drug Synergism
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Rhabdomyolysis / chemically induced
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / therapeutic use*
  • United States
  • United States Food and Drug Administration / standards

Substances

  • Coenzymes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyridines
  • Ubiquinone
  • Cholesterol
  • cerivastatin
  • coenzyme Q10